U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298772) titled 'A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors' on Dec. 09.
Brief Summary: This is an open label, multi-center, Phase Ib/II study to evaluate the safety, tolerability and efficacy of SHR-4375 injection in combination with other antitumor therapies in patients with advanced solid tumors.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Intervention:
DRUG: SHR-4375 Injection
SHR-4375 injection.
DRUG: Bevacizumab Injection
Bevacizumab injection.
DRUG: Fluorouracil injection
Fluorouracil injection.
DRUG: Calcium Folinate Injecti...